E
Emergent BioSolutions Inc.
EBS · NYSE · Healthcare · 237M
Price · close
$5.08
+5.39% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
5.2×
Price / net assetsP/B
0.5×
Enterprise value / EBITDAEV/EBITDA
2.7×
Free cash flow yieldFCF yield
57.7%
Return on equityROE
10.1%
Operating margin
14.8%
Net debt / EBITDAbalance-sheet strength
1.5×
Interest coverage
1.9×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.